These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34337800)

  • 1. Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis - Is there a difference?
    Leiherer A; Mündlein A; Brandtner EM; Säly CH; Ramadani H; Vonbank A; Mader A; Dopheide JF; Jylhä A; Lääperi M; Laaksonen R; März W; Fraunberger P; Kleber M; Drexel H
    J Intern Med; 2021 Dec; 290(6):1249-1263. PubMed ID: 34337800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the 2013 ACC/AHA cholesterol guidelines on contemporary clinical practice for patients with atherosclerotic coronary and peripheral arterial disease.
    Gunasekaran P; Jeevanantham V; Sharma S; Thapa R; Gupta K
    Indian Heart J; 2017; 69(4):464-468. PubMed ID: 28822512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lipid management in patients with coronary versus peripheral arterial disease.
    Sharma S; Thapa R; Jeevanantham V; Myers T; Hu C; Brimacombe M; Vacek JL; Dawn B; Gupta K
    Am J Cardiol; 2014 Apr; 113(8):1320-5. PubMed ID: 24560066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease.
    Miyazaki Y; Saita E; Kishimoto Y; Ibe S; Seki T; Miura K; Suzuki-Sugihara N; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    J Atheroscler Thromb; 2018 Sep; 25(9):821-828. PubMed ID: 29367522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidomic analysis of plasma lipoprotein fractions in myocardial infarction-prone rabbits.
    Takeda H; Koike T; Izumi Y; Yamada T; Yoshida M; Shiomi M; Fukusaki E; Bamba T
    J Biosci Bioeng; 2015 Oct; 120(4):476-82. PubMed ID: 26162515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary and peripheral artery plaques: do differences in plaque characteristics translate to differences in lipid management?
    Tsai S; Vega GL
    J Investig Med; 2020 Aug; 68(6):1141-1151. PubMed ID: 32474407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts.
    Tikkanen E; Jägerroos V; Holmes MV; Sattar N; Ala-Korpela M; Jousilahti P; Lundqvist A; Perola M; Salomaa V; Würtz P
    J Am Heart Assoc; 2021 Dec; 10(23):e021995. PubMed ID: 34845932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
    Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
    J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
    Kumakura H; Fujita K; Kanai H; Araki Y; Hojo Y; Kasama S; Iwasaki T; Ichikawa S; Nakashima K; Minami K
    J Atheroscler Thromb; 2015; 22(4):344-54. PubMed ID: 25296963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.
    Levin MG; Zuber V; Walker VM; Klarin D; Lynch J; Malik R; Aday AW; Bottolo L; Pradhan AD; Dichgans M; Chang KM; Rader DJ; Tsao PS; Voight BF; Gill D; Burgess S; Damrauer SM
    Circulation; 2021 Aug; 144(5):353-364. PubMed ID: 34139859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of novel cytokines in inflammation: Defining peripheral artery disease among patients with coronary artery disease.
    Ozkaramanli Gur D; Guzel S; Akyuz A; Alpsoy S; Guler N
    Vasc Med; 2018 Oct; 23(5):428-436. PubMed ID: 29638194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Plasma Betatrophin Levels and Coronary and Peripheral Artery Disease.
    Niki H; Kishimoto Y; Ibe S; Saita E; Sasaki K; Miura K; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    J Atheroscler Thromb; 2019 Jun; 26(6):573-581. PubMed ID: 30518729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
    Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
    Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in lipid control and statin drug use among diabetics with noncoronary atherosclerotic vascular disease vs those with coronary artery disease.
    Thapa R; Sharma S; Jeevanantham V; Hu C; Myers T; Vacek JL; Dawn B; Gupta K
    J Clin Lipidol; 2015; 9(2):241-6. PubMed ID: 25911081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum apolipoprotein A-I concentration differs in coronary and peripheral artery disease.
    Khan N; Khan J; Lyytikäinen LP; Lehtimäki T; Laurikka J; Oksala N
    Scand J Clin Lab Invest; 2020 Sep; 80(5):370-374. PubMed ID: 32491935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics.
    Nielsen NE; Olsson AG; Swahn E
    J Intern Med; 2000 Jan; 247(1):43-52. PubMed ID: 10672130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.